Thu, September 12, 2019
Wed, September 11, 2019
Tue, September 10, 2019
Mon, September 9, 2019
Fri, September 6, 2019
Thu, September 5, 2019
Wed, September 4, 2019
Tue, September 3, 2019
Fri, August 30, 2019
Thu, August 29, 2019
Wed, August 28, 2019
Tue, August 27, 2019
Mon, August 26, 2019
Fri, August 23, 2019
Thu, August 22, 2019
Wed, August 21, 2019
Tue, August 20, 2019
Mon, August 19, 2019

Paul Matteis Maintained (ACAD) at Hold with Increased Target to $28 on, Sep 3rd, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. with-increased-target-to-28-on-sep-3rd-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Paul Matteis of Stifel, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $24 to $28 on, Sep 3rd, 2019.

Paul has made no other calls on ACAD in the last 4 months.



There are 2 other peers that have a rating on ACAD. Out of the 2 peers that are also analyzing ACAD, 0 agree with Paul's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Paul


  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $40 on, Tuesday, August 27th, 2019
  • Danielle Brill of "Raymond James" Reiterated at Strong Buy with Increased Target to $43 on, Friday, May 31st, 2019

Publication Contributing Sources